Margaret von Mehren, the physician director for the clinical trials office at Fox Chase, has a commitment to developing new therapies for patients with gastrointestinal stromal tumors.
When facing gastrointestinal stromal tumors (GIST), where you go for care—and how quickly you are seen—can make a big difference. At Fox Chase Cancer Center in Philadelphia, we work with you to choose a treatment approach that offers the best chance of controlling your cancer, preserving function, and reducing the risk of recurrence.
At Fox Chase, we draw upon the nationally-recognized experience of our multidisciplinary medical team to make individualized decisions for your type and stage of GIST. The sarcoma team meets regularly to review new or challenging cases in depth and reach a consensus on treatment strategies. Through this coordinated approach, we strive to offer the most thorough and personalized care, as well as access to innovative therapies, for your cancer.
Request an appointment online or call 888-FOX-CHASE. For general information or to ask us a question, please visit our Contact Us page.
In our continued effort to protect out patients and staff against COVID-19, Fox Chase is now offering phone and video appointments for some patients.
